A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Urologic Cancers Bookmark and Share

Urology and Urologic Cancers

At City of Hope, our physicians are leading experts in treating patients with all types of urologic cancers. Just as no two patients are alike, cancer requires a unique treatment plan tailored to each individual to attain the best possible outcomes.
 
As one of a select number of institutions to attain the elite designation of  Comprehensive Cancer Center from the National Cancer Institute, City of Hope is acknowledged as a leader in cancer research and treatment.  Patients at City of Hope have access to:
 
  • Researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating urologic cancers
  • A multidisciplinary team of specialists in medical oncology, surgery and recovery.
  • Innovative clinical trials on the latest promising treatments, many unavailable anywhere but City of Hope
 
We are actively developing tomorrow’s treatment protocols today for bladder, kidney, prostate and testicular cancers. City of Hope was one of the first cancer centers in the United States to perform robotic-assisted prostatectomy using the  da Vinci® surgical system , and our surgeons have performed thousands of robotic urologic procedures.  The most significant benefits to patients are quicker recovery times and decreased blood loss compared to patients undergoing conventional “open incision” procedures.
 
City of Hope is home to California's largest prostate cancer program (according to data from the Office of Statewide Health Planning and Development, OSHPD) and maintains one of the country’s largest databases of  prostate cancer outcomes . City of Hope also maintains a large database of bladder cancer outcomes to aid in developing new treatment protocols. We have also developed more precise tools to monitor cancer progression in men who have opted for active surveillance for prostate cancer. 
 
Other leading-edge treatments offered here include robotic-assisted laparoscopic cystectomy and bilateral pelvic lymph node dissection for muscle-invasive bladder cancer. In fact, we have performed the largest number of robotic-assisted radical cystectomy procedures worldwide. In addition, we perform a variety of procedures to treat kidney cancer/renal masses, including radical nephrectomy, nephron-sparing surgery (open, laparoscopic, or robotic-assisted), cryoablation and radio-frequency ablation (performed percutaneously or laparoscopically).
 
The staff of the Division of Urology and Urologic Oncology, headed by  Timothy G. Wilson, M.D., Pauline and Martin Collins Family Chair in Urology, is recognized for its extensive expertise in minimally invasive surgery. We perform highly complex surgeries, such as retroperitoneal lymph node dissection for the treatment of testicular cancer. Because City of Hope offers the expertise of all cancer-related specialists in one location, patients receive greater continuity of care and more coordinated treatment planning.  The Division of Urology also sees many patients who have urologic problems as a result of treatment of non-urologic cancers.

Our research is focused on the early diagnosis and prevention of prostate cancer, intraoperative imaging, identification of high-risk prostate cancer patients and quality-of-life issues involving prostate cancer treatment. At City of Hope, we are evaluating outcomes and patterns of cancer care for both prostate and bladder cancer and better defining the benefits of robotic-assisted surgery.
 

Urologic Cancers Team

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Rick Leonard
Associate Vice President
Direct: 213-241-7218
Email: rleonard@coh.org

 
 

Urologic Cancers

Urology and Urologic Cancers

At City of Hope, our physicians are leading experts in treating patients with all types of urologic cancers. Just as no two patients are alike, cancer requires a unique treatment plan tailored to each individual to attain the best possible outcomes.
 
As one of a select number of institutions to attain the elite designation of  Comprehensive Cancer Center from the National Cancer Institute, City of Hope is acknowledged as a leader in cancer research and treatment.  Patients at City of Hope have access to:
 
  • Researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating urologic cancers
  • A multidisciplinary team of specialists in medical oncology, surgery and recovery.
  • Innovative clinical trials on the latest promising treatments, many unavailable anywhere but City of Hope
 
We are actively developing tomorrow’s treatment protocols today for bladder, kidney, prostate and testicular cancers. City of Hope was one of the first cancer centers in the United States to perform robotic-assisted prostatectomy using the  da Vinci® surgical system , and our surgeons have performed thousands of robotic urologic procedures.  The most significant benefits to patients are quicker recovery times and decreased blood loss compared to patients undergoing conventional “open incision” procedures.
 
City of Hope is home to California's largest prostate cancer program (according to data from the Office of Statewide Health Planning and Development, OSHPD) and maintains one of the country’s largest databases of  prostate cancer outcomes . City of Hope also maintains a large database of bladder cancer outcomes to aid in developing new treatment protocols. We have also developed more precise tools to monitor cancer progression in men who have opted for active surveillance for prostate cancer. 
 
Other leading-edge treatments offered here include robotic-assisted laparoscopic cystectomy and bilateral pelvic lymph node dissection for muscle-invasive bladder cancer. In fact, we have performed the largest number of robotic-assisted radical cystectomy procedures worldwide. In addition, we perform a variety of procedures to treat kidney cancer/renal masses, including radical nephrectomy, nephron-sparing surgery (open, laparoscopic, or robotic-assisted), cryoablation and radio-frequency ablation (performed percutaneously or laparoscopically).
 
The staff of the Division of Urology and Urologic Oncology, headed by  Timothy G. Wilson, M.D., Pauline and Martin Collins Family Chair in Urology, is recognized for its extensive expertise in minimally invasive surgery. We perform highly complex surgeries, such as retroperitoneal lymph node dissection for the treatment of testicular cancer. Because City of Hope offers the expertise of all cancer-related specialists in one location, patients receive greater continuity of care and more coordinated treatment planning.  The Division of Urology also sees many patients who have urologic problems as a result of treatment of non-urologic cancers.

Our research is focused on the early diagnosis and prevention of prostate cancer, intraoperative imaging, identification of high-risk prostate cancer patients and quality-of-life issues involving prostate cancer treatment. At City of Hope, we are evaluating outcomes and patterns of cancer care for both prostate and bladder cancer and better defining the benefits of robotic-assisted surgery.
 

Urologic Cancers Team

Urologic Cancers Team

Support This Program

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Rick Leonard
Associate Vice President
Direct: 213-241-7218
Email: rleonard@coh.org

 
 
Meet our doctors: Urologist Jonathan Yamzon on curingtesticular cancer

Meet our doctors: Urologist Jonathan Yamzon on curing testicular cancer

Testicular cancer is the most common form of cancer in men 15 to 34 years old. Yet it accounts for only 1 percent of all cancers in men in the United States. According to the American Cancer Society, ...

May 31, 2014

 
Urologic cancers: Dispatches from research’s frontlines

Urologic cancers: Dispatches from research’s front lines

Urologic cancers, including prostate cancer, kidney cancer and bladder cancer, are diagnosed in more than 381,000 Americans each year, and almost 60,000 people die from the diseases. City of Hope’s ph...

March 28, 2014

 
Meet our doctors: Surgeon Jennifer Linehan on prostatecancer

Meet our doctors: Surgeon Jennifer Linehan on prostate cancer

Prostate cancer is one of the most common types of cancer affecting men, with one in six American men receiving the diagnosis in their lifetime. In most cases, the disease grows slowly and causes no p...

December 7, 2013

 
City of Hope surgeon Laura Crocitto, M.D., talks aboutvitamin E and prostate cancer

City of Hope surgeon Laura Crocitto, M.D., talks about vitamin E and prostate cancer

You may have heard talk on the news about a link between vitamins and prostate cancer. A new study in the Journal of the American Medical Association  reveals that men should be more aware of the...

October 17, 2011

 
Why should men care about prostate cancer?

Why should men care about prostate cancer?

Timothy Wilson, M.D., Director, Prostate Cancer Program and Chief of the Division of Urology and Urologic Oncology Cancers at City of Hope, discusses why men should pay attention to prostate canc...

October 10, 2011

 
Urologic Cancers - Advances in Research and Treatments
 
Timothy Wilson, M.D.: Pauline & Martin Collins Family Chair in Urology, talks about City of Hope advances in research and treatments of urologic cancers.
 
For more information on prostate cancer: Watch the City of Hope prostate cancer YouTube playlist.
Urology and Urologic Oncology Research

City of Hopes's Division of Urology strives to improve quality of care through innovative research that helps expand our understanding of urologic cancers. This brochure provides the key areas of research and studies our division is focusing on.
 
 
The Division of Urology and Urologic Oncology at City of Hope offers a Fellowship in Urologic Oncology with special emphasis on minimally invasive and robotic techniques.
Clinical Trials
Our aggressive pursuit to discover better ways to help patients now – not years from now – places us among the leaders worldwide in the administration of clinical trials.
 
NEWS & UPDATES
  • September is Prostate Cancer Awareness Month. Here, Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Services at City of Hope, explains the importance of understanding the risk factors for the disease and ways to reduce those risks, as well as overall prostate health. “Wha...
  • ** Learn more about prostate cancer risk, plus prostate cancer research and treatment, at City of Hope. ** Learn more about getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and he...
  • Childhood cancer survival rates have increased dramatically over the past 40 years. More than 80 percent of children with cancer now survive five years or more, which is a tremendous feat. Despite the survival rate increase, cancer continues to be the No. 1 disease killer and second-leading cause of death in ch...
  • Although a stem cell transplant can be a lifesaving procedure for people diagnosed with a blood cancer or blood disorder, the standard transplant may not be appropriate for all patients. This is because the conditioning regimen (the intensive chemotherapy and/or radiation treatments preceding the transplant) is...
  • Brain tumor removal would seem to be the obvious course of action in the wake of a brain tumor diagnosis, but that’s not always the case. Some tumors are too difficult for many surgeons to reach or too close to areas that control vital functions. Removing them just proves too risky. A new device being con...
  • Hijacking the same sorts of viruses that cause HIV and using them to reprogram immune cells to fight cancer sounds like stuff of the future. Some scientists believe that the future is closer than we think – and are now studying the approach in clinical trials at City of Hope. Immunotherapy is a promising approa...
  • Nausea is the one of the most well-known, and dreaded, side effects of cancer treatment — and with good reason. Beyond the quality-of-life issues that it causes, severe nausea can prevent patients from receiving enough nutrients and calories at a time when they need every edge they can get. A few simple actions...
  • With Labor Day just around the corner, summer is on its way out. But just because summertime is ending doesn’t mean we can skip sunscreen. Protection from ultraviolet (UV) radiation is needed all year round. Exposure to UV radiation — whether from the sun or from artificial sources such as sunlamps used i...
  • Undergoing reconstructive surgery may seem like a forgone conclusion for survivors of breast cancer, but that doesn’t appear to be the case. A new study has found that most breast cancer survivors who undergo a mastectomy decide against surgical reconstruction of their breasts. The reasons for such a deci...
  • Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother. This year, City of Hope welcomed hundreds of hematopoietic cell transplant (HCT) recipients to the annual bone marrow transplant/HCT reun...
  • The burgeoning type 2 diabetes epidemic casts a pall over the health of America’s public. New research now shows the looming threat is getting worse. Much worse. A diabetes trends study published earlier this month in the Lancet Diabetes and Endocrinology by researchers at the federal Centers for Disease Contro...
  • An aspirin a day might help keep breast cancer away for some breast cancer survivors, a new study suggests. Obese women who have had breast cancer could cut their risk of a recurrence in half if they regularly take aspirin or other nonsteroidal anti-inflammatory drugs, called NSAIDs, report researchers from the...
  • Christine Crews isn’t only a fitness enthusiast, she’s also a personal trainer and fitness instructor. Being active defines her life. So when she was diagnosed with bladder cancer at age 30, she decided she absolutely couldn’t let the disease interfere with that lifestyle. And it didn’t. For t...
  • Cancer treatment and the cancer itself can cause changes in your sense of taste or smell. These side effects typically subside after treatment ends, but there are ways to help alleviate those bitter and metallic tastes in your mouth. Here are tips from the National Cancer Institute to help keeps tastes and food...
  • Immunotherapy — using one’s immune system to treat a disease — has been long lauded as the “magic bullet” of cancer treatments, one that can be more effective than the conventional therapies of surgery, radiation or chemotherapy. One specific type of immunotherapy, called adoptive T cell thera...